Guide price only. Final cost is confirmed after assessment.
Durolane Injection is a groundbreaking treatment for knee osteoarthritis pain available at London Cartilage Clinic. This hyaluronic acid-based therapy provides an effective and long-lasting solution for those suffering from joint pain, helping to restore mobility and improve quality of life.
Reviewed byProf Paul Lee MBBch, FRCS (Tr & Orth), PhDLast reviewed 1 May 2026
Durolane is a stabilised hyaluronic acid injection that restores lubrication and shock absorption in osteoarthritic joints, especially the knee.
It is commonly chosen when conservative care is insufficient but surgery is not yet indicated.
Durolane offers a practical balance of efficacy and convenience, particularly for patients who prefer a low-burden, non-surgical treatment plan.
Our specialist team uses diagnosis-led injection planning so treatment fits your joint pathology, activity level, and long-term goals.
Durolane’s unique formulation provides longer-lasting relief compared to some other hyaluronic acid treatments, making it a preferred choice for knee osteoarthritis management.
Many patients experience improvement in pain and mobility within a few weeks after receiving the Durolane Injection.
As with any medical procedure, there are potential side effects, but Durolane is generally well-tolerated. Our specialists will discuss any concerns you may have during your consultation.
The main symptoms of osteoarthritis are pain and stiffness that’s localised to certain joints. However, it can also include:
It’s normal for patients to experience slight discomfort during the injection, although this can simply be avoided through the use of a numbing agent or localised anaesthetic.
The exact duration of effectiveness of Durolane injections will depend on a range of factors, such as age, degree of injury, the joints affected, and underlying health conditions. A medical professional will be able to provide an accurate forecast during a consultation. However, Durolane is considered a long lasting treatment for relieving knee pain and restoring mobility relative to other options.
Still have more specific concerns?
Free Discovery CallLondon Cartilage Clinic
Clinical updates, cartilage treatment guidance, and recovery-focused articles from our specialist team.
Microfracture and ChondroFiller injection deliver equivalent relief in the first year but diverge thereafter because they produce different repair tissue: microfracture generates fibrocartilage that deteriorates under sustained loading (62% failure at four years), whilst ChondroFiller creates hyaline-like cartilage that withstands cumulative compression.
ChondroFiller injection treats diffuse cartilage damage that surgery cannot, via matrix-induced chondrogenesis in Grade III–IV lesions with no published size ceiling (except hip ~6 cm²); candidacy depends on joint mechanical stability, MRI findings, and health profile, not symptom severity or age.
Knee cartilage grades (0–4) describe depth of structural damage, not pain; since cartilage has no nerve supply, pain stems from bone marrow lesions and synovial inflammation instead.
